← Back to Search

Patients with suspected Barrett's Esophagus or at risk for esophageal cancer for Esophageal Cancer (BEST-RPP Trial)

N/A
Recruiting
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months
Awards & highlights

BEST-RPP Trial Summary

Recent advancements in swallowable esophageal cell-collection devices (SECD) offer a safe, minimally invasive, accurate, and low-cost alternative to esophageal screening without the need for an upper endoscopy. The BEST-RPP study aims to evaluate the acceptability and feasibility of using this novel approach to screen for Barrett's Esophagus (BE) and Esophageal Carcinoma (EAC) in rural primary care clinic settings in Oregon.

Eligible Conditions
  • Esophageal Cancer

BEST-RPP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of the use of SECD: Number enrolled
Feasibility of the use of SECD: Number of providers who indicate willingness to be trained and train clinic staff
Feasibility of the use of SECD: Number of referrals
+4 more
Secondary outcome measures
Access: time to full diagnostic work up for patients with positive SECD results

BEST-RPP Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with suspected Barrett's Esophagus or at risk for esophageal cancerExperimental Treatment1 Intervention
Patients who receive primary care in a rural settings and are in need of screening for Barrett's Esophagus or esophageal cancer.

Find a Location

Who is running the clinical trial?

OHSU Knight Cancer InstituteLead Sponsor
230 Previous Clinical Trials
2,090,616 Total Patients Enrolled
Kuni FoundationUNKNOWN
1 Previous Clinical Trials
150 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
975 Previous Clinical Trials
7,386,102 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~73 spots leftby Jan 2025